Download PDF
CC BY-NC-ND 4.0 · Arq Neuropsiquiatr 2017; 75(07): 446-450
DOI: 10.1590/0004-282X20170069
ARTICLES

ID-Migraine™ questionnaire and accurate diagnosis of migraine

Questionário ID-Migraine™ e o adequado diagnóstico da migrânea
Ana Carolina Musser Tavares de Mattos
1   Universidade Federal Fluminense, Hospital Universitário Antçnio Pedro, Ambulatório de Cefaleia, Niterói RJ, Brasil;
,
Jano Alves de Souza
1   Universidade Federal Fluminense, Hospital Universitário Antçnio Pedro, Ambulatório de Cefaleia, Niterói RJ, Brasil;
2   Universidade Federal Fluminense, Departamento de Neurologia, Niterói RJ, Brasil;
,
Pedro Ferreira Moreira Filho
1   Universidade Federal Fluminense, Hospital Universitário Antçnio Pedro, Ambulatório de Cefaleia, Niterói RJ, Brasil;
2   Universidade Federal Fluminense, Departamento de Neurologia, Niterói RJ, Brasil;
,
Mauro Eduardo Jurno
1   Universidade Federal Fluminense, Hospital Universitário Antçnio Pedro, Ambulatório de Cefaleia, Niterói RJ, Brasil;
3   Faculdade de Medicina de Barbacena, Departamento de Neurologia, Barbacena MG, Brasil;
,
Luis Guilhermo Coca Velarde
4   Universidade Federal Fluminense, Instituto de Matemática e Estatística, Niterói RJ, Brasil.
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

ABSTRACT

Objective

To analyze the applicability of the Portuguese version of ID-MigraineTM in a sample of Brazilian patients.

Methods

Patients with headache were recruited from the neurology outpatient clinic of a tertiary hospital and submitted to the ID-MigraineTM questionnaire. The diagnosis of headache was made according to the ICHD-2 criteria.

Results

Of the 232 patients, 86% had migraine. The questionnaire showed a sensitivity of 92% (95%CI, 88% to 95%), specificity of 60% (95%CI, 43% to 77%) and a positive predictive value of 93% (95%CI, 89% to 96%).

Discussion

Our results were similar to other international studies of the ID-MigraineTM application. The Portuguese version is considered easy to use, and an appropriate screening tool for migraine diagnosis in our sample.

Conclusion

Considering the characteristics of our health system, we can infer that this questionnaire would be beneficial in a Brazilian primary care setting; however, more studies are necessary.

RESUMO

Objetivo

Analisar a aplicabilidade da versão em Português do ID-MigraineTM em uma amostra de pacientes brasileiros.

Métodos

Pacientes com cefaleia foram recrutados no Ambulatório de Neurologia de um hospital terciário e submetidos ao questionário ID-MigraineTM. O diagnóstico de cefaleia foi feito de acordo com os critérios da ICHD-2.

Resultados

Dos 232 pacientes, 86% tinham enxaqueca. O questionário apresentou sensibilidade de 92% (IC de 95% 88% a 95%), especificidade de 60% (IC de 95% 43% a 77%) e valor positivo preditivo positivo de 93% (IC 95 89% a 96%).

Discussão

Nossos resultados foram similares a outros estudos mundiais de aplicação do ID-MigraineTM. A versão em Português é considerada de fácil utilização, sendo uma ferramenta adequada para triagem diagnóstica de migrânea em nossa amostra.

Conclusão

Considerando as características do nosso sistema de saúde, podemos inferir que este questionário seria útil nos serviços primários de saúde brasileiros, porém mais estudos são necessários.

migraine disorders - surveys and questionnaires - headache
transtornos de enxaqueca - inquéritos e questionários - cefaleia


Publication History

Received: 16 August 2016

Accepted: 30 March 2017

Article published online:
05 September 2023

© 2023. Academia Brasileira de Neurologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 

  • References

  • 1 Stovner L, Hagen K, Jensen R, Katsarava Z, Lipton R, Scher A et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia. 2007;27(3):193-210. https://doi.org/10.1111/j.1468-2982.2007.01288.x
  • 2 Queiroz LP, Peres MF, Piovesan EJ, Kowacs F, Ciciarelli MC, Souza JA et al. A nationwide population-based study of migraine in Brazil. Cephalalgia. 2009;29(6):642-9. https://doi.org/10.1111/j.1468-2982.2008.01782.x
  • 3 Lipton RB, Scher AI, Kolodner K, Liberman J, Steiner TJ, Stewart WF. Migraine in the United States: epidemiology and patterns of health care use. Neurology. 2002;58(6):885-94. https://doi.org/10.1212/WNL.58.6.885
  • 4 The International Headache Society. The international classification of headache disorders: 2nd edition. Cephalalgia. 2004;24(Suppl. 1):9-160.
  • 5 Bigal ME, Bordini CA, Speciali JG. Etiology and distribution of headaches in two Brazilian primary care units. Headache. 2000;40(3):241-7. https://doi.org/10.1046/j.1526-4610.2000.00035.x
  • 6 Vincent MB, de Carvalho JJ. Primary headache care delivery by nonspecialists in Brazil.. Cephalalgia. 1999;19(5):520-4. https://doi.org/10.1046/j.1468-2982.1999.019005520.x
  • 7 Diener HC, Limmroth V. Medication-overuse headache: a worldwide problem. Lancet Neurol. 2004;3(8):475-83. https://doi.org/10.1016/S1474-4422(04)00824-5
  • 8 Bekkelund SI, Albretsen C. Evaluation of referrals from general practice to a neurological department. Fam Pract. 2002;19(3):297-9. https://doi.org/10.1093/fampra/19.3.297
  • 9 Mathers CD, Bernard C, Iburg KM, Inoue M, Fat DM, Shibuya K et al. Global Burden of Disease in 2002: data sources, methods and results. 2004 [cited year month day] . Available from: http://www.who.int/healthinfo/paper54.pdf
  • 10 Antonaci F, Nappi G, Galli F, Manzoni GC, Calabresi P, Costa A. Migraine and psychiatric comorbidity: a review of clinical findings. J Headache Pain. 2011;12(2):115-25. https://doi.org/10.1007/s10194-010-0282-4
  • 11 Dahlof CG, Solomon GD. The burden of migraine to the individual sufferer: a review. Eur J Neurol. 1998;5(6):525-33. https://doi.org/10.1046/j.1468-1331.1998.560525.x
  • 12 Edmeads J, Mackell JA. The economic impact of migraine: an analysis is of direct and indirect costs. Headache. 2002;42(6):501-9. https://doi.org/10.1046/j.1526-4610.2002.04262.x
  • 13 Lipton RB, Stewart WF, von Korff M. Burden of migraine: societal costs and therapeutic opportunities. Neurology. 1997;48(3 Suppl 3):S4-9. https://doi.org/10.1212/WNL.48.3_Suppl_3.4S
  • 14 Lipton RB, Dodick D, Sadovsky R, Kolodner K, Endicott J, Hettiarachchi J et al. A self-administered screener for migraine in primary care: the ID Migraine validation study. Neurology. 2003;61(3):375-82. https://doi.org/10.1212/01.WNL.0000078940.53438.83
  • 15 Streel S, Donneau AF, Dardenne N, Hoge A, Bruyère O, Albert A et al. Validation of an extended French version of ID MigraineTM as a migraine-screening tool. Cephalalgia. 2015;35(5):437-42. https://doi.org/10.1177/0333102414544910
  • 16 Brighina F, Salemi G, Fierro B, Gasparro A, Balletta A, Aloisio A et al. A validation study of an Italian version of the “ID Migraine”. Headache. 2007;47(6):905-8. https://doi.org/10.1111/j.1526-4610.2006.00628.x
  • 17 Karli N, Ertas M, Baykan B, Uzunkaya O, Saip S, Zarifoglu M et al. The validation of ID Migraine screener in neurology outpatient clinics in Turkey. J Headache Pain. 2007;8(4):217-23. https://doi.org/10.1007/s10194-007-0397-4
  • 18 Gil-Gouveia R, Martins I. Validation of the Portuguese version of ID-Migraine. Headache. 2010;50(3):396-402. https://doi.org/10.1111/j.1526-4610.2009.01449.x
  • 19 Cousins G, Hijazze S, Van de Laar FA, Fahey T. Diagnostic accuracy of the ID Migraine: a systematic review and meta-analysis. Headache. 2011;51(7):1140-8. https://doi.org/10.1111/j.1526-4610.2011.01916.x